135 related articles for article (PubMed ID: 8662705)
1. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
Renné T; Dedio J; Meijers JC; Chung D; Müller-Esterl W
J Biol Chem; 1999 Sep; 274(36):25777-84. PubMed ID: 10464316
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2.
Renné T; Sugiyama A; Gailani D; Jahnen-Dechent W; Walter U; Müller-Esterl W
Int Immunopharmacol; 2002 Dec; 2(13-14):1867-73. PubMed ID: 12489801
[TBL] [Abstract][Full Text] [Related]
5. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
Page JD; Colman RW
J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
[TBL] [Abstract][Full Text] [Related]
6. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
Hock J; Vogel R; Linke RP; Müller-Esterl W
J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
[TBL] [Abstract][Full Text] [Related]
8. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
Page JD; You JL; Harris RB; Colman RW
Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
Veloso D; Silver LD; Hahn S; Colman RW
Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
[TBL] [Abstract][Full Text] [Related]
10. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
[No Abstract] [Full Text] [Related]
11. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
Reddigari SR; Kaplan AP
Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
Bock PE; Shore JD; Tans G; Griffin JH
J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
[TBL] [Abstract][Full Text] [Related]
15. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
Olson ST; Francis AM; Sheffer R; Choay J
Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
Renné T; Gailani D; Meijers JC; Müller-Esterl W
J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
[TBL] [Abstract][Full Text] [Related]
17. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
Kerbiriou DM; Bouma BN; Griffin JH
J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
[TBL] [Abstract][Full Text] [Related]
19. Identification of an endothelial cell binding site on kininogen domain D3.
Herwald H; Hasan AA; Godovac-Zimmermann J; Schmaier AH; Müller-Esterl W
J Biol Chem; 1995 Jun; 270(24):14634-42. PubMed ID: 7540175
[TBL] [Abstract][Full Text] [Related]
20. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity.
Tait JF; Fujikawa K
J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
